Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

Responsive image


Draft:Robert Colebunders

  • Comment: Almost all references are written by the subject of the article so cannot be considered independent. I suspect he could pass WP:NPROF, e.g. WP:NPROF#C1. In quite a few places the article states that his work had a significant impact, but the only reference for these statements is his work itself. If there were independent sources referring to the impact of his work, either in practice or in academia, then I would be more convinced. I can see that there has been a lot done to make the article less promotional than the previous version. Mgp28 (talk) 15:48, 30 June 2024 (UTC)
  • Comment: Still the same issues as my last decline. A lot of 'Career' is unsourced, all of 'Personal life' is unsourced - RichT|C|E-Mail 14:36, 24 January 2024 (UTC)
  • Comment: A lot of 'Career' is unsourced, all of 'Personal life' is unsourced - RichT|C|E-Mail 16:47, 10 October 2023 (UTC)


Robert Colebunders
Born (1950-04-19) 19 April 1950 (age 74)
NationalityBelgian
Alma materUniversity of Antwerp
Free University of Brussels
Institute of Tropical Medicine Antwerp
Scientific career
FieldsInfectious Diseases
InstitutionsGlobal Health Institute
University of Antwerp
Institute of Tropical Medicine Antwerp
Websiteuantwerpen.be/en/staff/robert-colebunders/my-website/

Robert Colebunders (born 19 April 1950) is a Belgian clinician and researcher specialising in infectious diseases and epidemiology, particularly in the study of emerging pathogens and tropical diseases[1][2]. He has made significant contributions to understanding and managing diseases such as Ebola, AIDS, tuberculosis and onchocerciasis. Colebunders investigated major outbreaks, including the Ebola and Ebola and Marburg virus epidemics, and has contributed to research on COVID-19 and monkeypox. His current work focuses on onchocerciasis-associated epilepsy (OAE), a condition prevalent in regions where river blindness (onchocerciasis) is endemic. He is Professor Emeritus at the Institute of Tropical Medicine Antwerp (ITM), Belgium, and continues to lead international research efforts on infectious diseases at the Global Health Institute.

  1. ^ Coalition for Equitable Research in Low-Resource Settings. "Robert Colebunders". CERCLE - Coalition for Equitable Research in Low-Resource Settings. Retrieved 23 July 2024.
  2. ^ International Society for Infectious Diseases (3 June 2020). "ISID Council Members - ISID". Retrieved 23 July 2024.

Previous Page Next Page








Responsive image

Responsive image